Revenio Group Corporation   Stock Exchange Release March 26, 2014 at 4.05
p.m.

NOTICE PURSUANT TO SECTION 5, CHAPTER 9 OF THE SECURITIES MARKET
ACT

Revenio Group Corporation has today received a notification of change
in
holdings in accordance with Chapter 9, Section 5 of the Securities Markets
Act
that Eyemaker's Finland Oy's share of the total number of shares and
voting
rights in Revenio Group Corporation has decreased to less than one
twentieth
(1/20).

Eyemaker's Finland Oy now holds 350,000 shares in Revenio
Group Corporation,
which is 4.45 percent of the company's shares and voting
rights.

The total number of Revenio Group Corporation's shares recorded in the
trade
register is 7,856,519.

Revenio Group Corporation

Olli-Pekka
Salovaara
President and CEO

For further information, please
contact:

Olli-Pekka Salovaara, President & CEO, +358 (0)40 567 5520
     (mobile)
olli-pekka.salovaara@revenio.fi
http://www.revenio.fi/


DISTRIBUTION:

     
NASDAQ
OMX Helsinki

Financial Supervisory Authority (FIN-FSA)

Principal
media

www.revenio.fi



The Revenio Group in brief

Revenio is a Finnish
health tech group whose core business is tonometers. The
Revenio Health Tech
segment comprises the business operations of Icare Finland
Oy. The widely
patented Icare product family is the current cornerstone of the
Group's
success. Revenio seeks vigorous growth in health technology, both
organically
and through acquisitions and mergers. The Revenio Group also
includes other
business operations, which are grouped under the Technology and
Services
segment. This segment's operations have a shared global market and
represent
the cutting edge of technology products and services in their
industry. These
businesses are extremely profitable in their industries and
generate positive
cash flow.

In 2013, the Revenio Group's net sales totaled EUR 25.7 million,
with its
operating margin standing at 21.7%. The Revenio Group Corporation is
listed on
NASDAQ OMX Helsinki.




[HUG#1771921]